DeepValuesResearch
CompaniesInsightsMarketGurusPrinciplesBuffett ArchivePersonal FinanceBusiness NotesLatestBullish stocksNeutral stocksBearish stocksSectorsMost covered For agents & developers

ABBVHealthcare · Drug Manufacturers - General

AbbVie

DeepValues Research covers AbbVie (ABBV) with 11 research reports since Feb 15, 2026. The latest Deep Value Intelligence report (Sep 13, 2026) ends with a Bullish stance (2.35/5), with the stock at $257 against a headline intrinsic value of $151. Sector: Healthcare · Drug Manufacturers - General. Bullish since Aug 2, 2026 (previously Neutral); 1 stance change across 10 scored reports since Mar 31, 2026.

Latest stanceBullish2.35
Reports11since Feb 15, 2026
Latest reportEN

Stance history

Bullish since Aug 2, 2026 (previously Neutral); 1 stance change across 10 scored reports since Mar 31, 2026.

  1. Neutral2.55
  2. Neutral2.35
  3. Neutral2.35
  4. Neutral2.35
  5. Neutral2.38
  6. Neutral2.35
  7. Bullish2.28
  8. Bullish2.35
  9. Bullish2.28
  10. Bullish2.35

Research timeline

  1. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Bullish (2.35/5) on AbbVie (ABBV), Sep 13, 2026. Price $257 vs intrinsic value $151. AbbVie (ABBV) represents a high-quality compounder undergoing a…

    Bullish2.35EN31 min

  2. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Bullish (2.28/5) on AbbVie (ABBV), Aug 30, 2026. Price $255 vs intrinsic value $159. (CONCISE) AbbVie (ABBV) is a wonderful business at a fair price.

    Bullish2.28EN31 min

  3. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Bullish (2.35/5) on AbbVie (ABBV), Aug 16, 2026. Price $249 vs intrinsic value $157. AbbVie (ABBV) is a fundamentally elite, highly cash-generative…

    Bullish2.35EN27 min

  4. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Bullish (2.28/5) on AbbVie (ABBV), Aug 2, 2026. Price $251 vs intrinsic value $127. (CONCISE) AbbVie (ABBV) is a high-quality compounder actively…

    Bullish2.28EN33 min

  5. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Neutral (2.35/5) on AbbVie (ABBV), Jul 19, 2026. Price $254 vs intrinsic value $282. AbbVie remains a high-quality pharmaceutical franchise with clear…

    Neutral2.35EN37 min

  6. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Neutral (2.38/5) on AbbVie (ABBV), Jul 5, 2026. Price $261. AbbVie remains a classic high-cash-flow pharmaceutical franchise with strong gross margins…

    Neutral2.38EN31 min

  7. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Neutral (2.35/5) on AbbVie (ABBV), Jun 21, 2026. Price $216. AbbVie remains a high-quality cash-generative pharmaceutical franchise with a clear economic…

    Neutral2.35EN35 min

  8. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Neutral (2.35/5) on AbbVie (ABBV), Jun 7, 2026. Price $227. AbbVie remains a classic high-cash-flow, wide-portfolio pharmaceutical franchise, but the…

    Neutral2.35EN30 min

  9. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Neutral (2.35/5) on AbbVie (ABBV), May 24, 2026. Price $216. AbbVie remains a high-quality cash-generating pharmaceutical franchise with clear economic…

    Neutral2.35EN36 min

  10. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Neutral (2.55/5) on AbbVie (ABBV), Mar 31, 2026. Price $217. AbbVie is a highly profitable pharmaceutical franchise navigating a major product…

    Neutral2.55EN33 min

  11. Deep Value Intelligence

    AbbVie (ABBV) Deep Value Intelligence Report

    Deep Value Intelligence report on AbbVie (ABBV), Feb 15, 2026. - ### Risk Management Commentary: AbbVie (ABBV) - The Bull Case (Growth & Momentum): The…

    EN35 min

Compare with other Healthcare companies

All Healthcare stocks
CompanyIndustryLatest stancePrice · valueDateReports
ABBVAbbVie Drug Manufacturers - General Bullish2.35 $257 · $151 11
JNJJohnson & Johnson Drug Manufacturers - General Neutral3.08 $264 · $184 3
AZNAstraZeneca Drug Manufacturers - General Bullish3.33 $161 · $198 1
LLYEli Lilly and Drug Manufacturers - General Neutral3.28 $920 2
GRDN Medical Care Facilities Bearish3.16 $40 · $14 1
ALLOAllogene Therapeutics Biotechnology Bearish3.10 $1 1
MRNA Biotechnology Neutral3.01 $199 · $448 1
CRSPCRISPR Therapeutics Biotechnology Neutral2.30 $56 1
INSMInsmed Biotechnology Bearish2.52 $118 1

Charts from the latest report

Open report
Fundamentals Key MetricsFundamentals Key MetricsFundamentals Key MetricsYear Financial Metrics (Profitability)Year Financial Metrics (Health)Revenue BreakdownLatest Earnings SnapshotCurrent vs. 10-Year Historical Average ComparisonBuffett-Style Owner Earnings DCFDCF Cross-Check Against Provided Model PackMarket Metrics Interpretation